Antifungal nano-in-microparticle gel for enhanced bioavailability
Introducing a novel gel formulation incorporating antifungal nano-in-microparticles derived from ginger and seaweed extracts. This technology increases bioavailability and effectiveness against biofilms, offering a promising natural-based solution for fungal infections.
Overview
The antifungal nano-in-microparticle gel is a groundbreaking formulation designed to enhance the bioavailability and efficacy of natural antifungal agents. By leveraging the antimicrobial properties of ginger and seaweed extracts, this gel offers a potent solution against stubborn biofilms and fungal infections. The unique delivery system, utilizing nano-in-microparticles, ensures increased surface contact and prolonged action, making it an ideal candidate for medical and personal care products targeting fungal issues.
Technical specifications
- Natural-based extracts: Utilizes ginger and seaweed peptides known for their antimicrobial and antifungal properties.
- Nano-in-microparticles: Advanced encapsulation technique increases surface area for enhanced contact with biofilms.
- Gel formulation: Composed of carrageenan, a seaweed-derived gel, to ensure high adhesion and stability.
- FDA-approved components: Uses lecithin and a minimal amount of surfactant for safe application.
- Spray drying technique: Produces powder form of nano-in-microparticles, facilitating incorporation into gels.
Technology readiness level
Currently at Technology Readiness Level 4, this technology has been validated at the laboratory level. Ongoing research focuses on optimizing formulation and testing antimicrobial and antifungal effectiveness in real-world conditions.
About The University of Queensland
The University of Queensland is a large, multi-campus public research university in Brisbane with a comprehensive academic and research profile. Industry partners engage through hospital-embedded laboratories and clinical sites, pilot testbeds, and field campuses across Queensland that enable prototyping, trials, and validation in real-world settings. Co-location with major health precincts and proximity to Brisbane’s innovation districts make collaboration and talent access straightforward, while on-campus incubation and professional education support workforce upskilling. Research is supported by competitive national funding from the Australian Research Council and the National Health and Medical Research Council, alongside state and industry investment. A dedicated technology transfer office and commercialization company manage IP, licensing, sponsored research agreements, and spin-out formation.
delivered to your inbox.